The anticholinesterase effects presented here encourage us to propose extensive studies to determine the compounds responsible for the inhibitory effect and the kinetic mechanisms exerted against AChE in order to include this EO or their components in a natural pharmaceutical formulation as adjuvant therapy for Alzheimer’s disease. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.